본문 바로가기
intron logo

logo

  • About us
    • BUSINESS
    • R&BD HISTORY
    • OUR EXPERTISE
    • OUR PEOPLE
    • INSIDE iNtRON
  • Platform
    • TECHNOLOGY OVERVIEW
    • PHAGERIARUS®
    • PHAGERUS®
    • PHAGERIA®
    • itLysin®
    • im-MucoDr®
  • AD / BC
    • AD / BC
    • Triangle Hypothesis
  • B.E.C. Project
    • B. E. C. PROJECT
  • Partnering
    • PARTNERING
    • CONTACT
  • Address.

    iNtODEWORLD
    1500 District Avenue,
    Suite 2097, Burlington, MA 01803, USA

    iNtRON Biotechnology
    Suite 701~704, 137, Sagimakgol-ro, Jungwon-gu,
    Seongnam-si, Gyeonggi-do, Republic of Korea

  • Email.

    partner@intron.co.kr

  • Shrimp EMS (Early Mortality Syndrome) and its solution

    08 December,2017
  • iNtRON Biotechnology, TonaBACASE, the newly adopted name of SAL200 by ..

    13 March,2017
  • Urgent Need for New Antibiotics Against Gram Negative Bacteria – “Post..

    01 March,2017
  • N-Rephasin® SAL200 IRB(Institutional Review Board) Approval

    03 January,2017
1 2 3 4
  • Address.
    iNtODEWORLD
    1500 District Avenue,
    Suite 2097, Burlington, MA 01803, USA
    iNtRON Biotechnology
    Suite 701~704, 137, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
  • Email.
    partner@intron.co.kr

(C) 2022. iNtODEWORLD. Inc. All rights reserved.